Journal of Genetic Counseling

, Volume 15, Issue 6, pp 465–476

The Complexity and Challenges of Genetic Counseling and Testing for Inflammatory Bowel Disease

Professional Issues

Inflammatory bowel disease (IBD) is an umbrella term referring to two chronic idiopathic intestinal diseases: ulcerative colitis (UC) and Crohn’s disease (CD). Both UC and CD are characterized by immune activation that leads to symptoms, but the location, severity and behavior of the inflammation varies among individuals and in characteristic ways between UC and CD. A majority of patients with IBD are diagnosed in young adulthood, but the response to therapy is variable and difficult to predict, with some patients demonstrating a prompt and effective remission while others have continuous symptoms that do not respond to existing medical options. Surgery remains a frequent and necessary occurrence among patients with IBD, but in UC it is considered curative, while in CD only temporizing. Clinical observations, epidemiological studies, and molecular genetics have provided strong evidence that both genetic and environmental factors are important determinants for disease susceptibility. In recent years, a number of genes have been identified that associate with CD and UC, although the clinical utility of these discoveries in patients or in susceptible family members has not been determined. Nonetheless, it is hoped that these fundamental advances in our understanding of IBD will lead to better therapies for patients and prevention strategies for those who are susceptible. Effective incorporation of clinical genetic testing for IBD into practice will require appropriate education and counseling.

KEY WORDS:

Inflammatory bowel disease genetic counseling genetic testing disease progression ulcerative colitis Crohn’s disease 

References

  1. Aktan-Collan, K., Haukkala, A., et al. (2001). Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): A prospective follow-up study. Int J Cancer, 93(4), 608–611.PubMedCrossRefGoogle Scholar
  2. Allchin, W. H. (1909). Ulcerative Colitis, An address introductory to the subject. Proc R Soc Med, 2, 59–175.PubMedGoogle Scholar
  3. Alvarez-Lobos, M., Arostegui, J. I., Sans, M., et al. (2005). Alvarez-Lobos M, Arostegui JI, Sans M, Tassies D, Plaza S, Delgado S, Lacy AM, Pique JM, Yague J, Panes J. Ann Surg, 242(5), 693–700. Crohn’s disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence.PubMedCrossRefGoogle Scholar
  4. Andres, P. G., & Friedman, L. S. (1999). Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am, 28(2), 255–281, vii.Google Scholar
  5. Annese, V., Andreoli, A., Astegiano, M., et al. (2001). Clinical features in familial casesof Crohn’s disease and ulcerative colitis in Italy: A GISC Study. Italian study group for the disease of colon and rectum. Am J Gastroenterol, 96, 2939–2945.Google Scholar
  6. Aronowitz, R. A. (1998). The rise and fall of the hPsychosomatic Hypothesis in Ulcerative Colitis. In R. A. Aronowitz (Ed.): Making sense of illness (pp. 57–83). New York, NY: Cambridge University Press.Google Scholar
  7. Babul, R., Adam, S., et al. (1993). Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease. JAMA, 270(19), 2321–2325.Google Scholar
  8. Basset, C., Holton, J., et al. (2004). Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci, 49(9), 1425–1432.PubMedCrossRefGoogle Scholar
  9. Bernstein, C. N., Blanchard, J. F., et al. (2001). Cancer risk in patients with inflammatory bowel disease: A population-based study. Cancer, 91(4), 854–862.PubMedCrossRefGoogle Scholar
  10. Bernstein, C. N., Blanchard, J. F., et al. (1999). Epidemiology of CD and ulcerative colitis in a central Canadian province: A population-based study. Am J Epidemiol, 149(10), 916–924.PubMedGoogle Scholar
  11. Bonen, D, & Cho, J. (2003). The Genetics of Inflammatory Bowel Disease. Gastroenterology, 124, 521–536.PubMedCrossRefGoogle Scholar
  12. Bottorff, J. L., Ratner, P. A., Balneaves, L. G., et al. (2002). Women’s interest in genetic testing for breast cancer risk the influence of sociodemographics and knowledge. Cancer Epidemiol Biomarkers & Prevent, 11, 89–95.Google Scholar
  13. Brant, S. R., Picco, M. F., Achkar, J. P., et al. (2003). Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis, 9(5), 281–289.PubMedCrossRefGoogle Scholar
  14. Bratt, O., Damber, J. E., Emanuelsson, M., et al. (2000). Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer, 36(2), 235–241.PubMedCrossRefGoogle Scholar
  15. Calkins, B. M. (1989) A Meta-Analysis of the Role of Smoking in Inflammatory Bowel Disease. Dig Dis Sci 34, 1841–1854.PubMedCrossRefGoogle Scholar
  16. Carr, I., & Mayvberry, J. F. (1999). The effects of migration on ulcertive colitis: A three-year prospective study among Europeans and first- and second-generation South Asians in Leicester (1991–1994). Am J Gastroenterol, 94, 2918–2922.PubMedGoogle Scholar
  17. Cavanaugh, J. A., Adams, K. E., et al. (2003). CARD15/NOD2 risk alleles in the development of CD in the Australian population. Ann Hum Genet, 67(Pt 1), 35–41.PubMedCrossRefGoogle Scholar
  18. Cho, J. H., Nicolae, D. L., et al. (1998). Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A, 95(13), 7502–7507.PubMedCrossRefGoogle Scholar
  19. Cosnes, J. (2004). Tobacco and IBD: Relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol, 18(3), 481–496.PubMedCrossRefGoogle Scholar
  20. Cuffari, C., Hunt, S., Bayless, E. (2001). Utilisation of erythrocyte-thioguanine metabolite levels to optimise azaththioprine therapyu in patiens with inflammatory bowel disease. Gut, 48, 642–466.PubMedCrossRefGoogle Scholar
  21. Dashiell, G. F., Kirsner, J. B., Kotz, A. P., et al. (1951). Regional enteritis: A follow-up Stud of Forty Cases. Med Clin North Am, 35, 227–241.PubMedGoogle Scholar
  22. De Boer, M., Grootenhuis, M., Derkx, B., & Last, B. (2005). Health-related Quality of Life and Psychosocial Functioning of Adolscents with Inflammatory Bowel Disease. Inflamm Bowel Dis, 11(4), 400–406.PubMedCrossRefGoogle Scholar
  23. Duerr, R. H., Barmada, M. M., et al. (2000). High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet, 66(6), 1857–1862.PubMedCrossRefGoogle Scholar
  24. Esters, N., Pierik, M., et al. (2004). Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am J Gastroenterol, 99(2), 299–305.PubMedCrossRefGoogle Scholar
  25. Farmer, R. G., Michener, W. M., et al. (1980). Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol, 9(2), 271–277.Google Scholar
  26. Florin, T. H., Pandeya, N., et al. (2004). Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: Its influence on the clinical behaviour of these diseases. Gut, 53(7), 973–979.PubMedCrossRefGoogle Scholar
  27. Frisch, M., Olsen, J., & Andersen, P. K. (1996). Follow-up time bias and Crohn’s disease. Lancet, 347, 1551.PubMedCrossRefGoogle Scholar
  28. Galbraith, S. S., Drolet, B. A., Kugathasan, S., Paller, A. S., & Esterly, N. B. (2005). Asymptomatic inflammatory bowel disease presenting with mUC ocutaneous findings. Pediatrics, 116(3), e439–e444.PubMedCrossRefGoogle Scholar
  29. Gleason, T. R., & Evans, M. E. (2004). Perceived vulnerability: A comparison of parents and children. J Child Health Care, 8(4), 279–287.PubMedCrossRefGoogle Scholar
  30. Gonzalez, S., Rodrigo, L., Martinez-Borra, J., et al. (2003). TNF-alpha -308A promotor polymorphism is assoicated with enhanced TNF-alpha production and inflmmatory activity in Crohn’s patients with fistulizing disease. Am J Gastroenterol, 98, 1101–1106.PubMedGoogle Scholar
  31. Grosse, S. D., Khoury, M. J. (2006). What is the clinical utility of Genetic Testing? Genetics IN Medicine, 8(7), 448–450.PubMedCrossRefGoogle Scholar
  32. Halfvarson, J., Bodin, L., Tysk, C., et al. (2003). inflammatory bowel disease in a swedish cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology, 124, 1067–1773.CrossRefGoogle Scholar
  33. Hampe, J., Heymann, K., Kruis, W., et al. (2000). Anticipation in Inflammatory Bowel Disease: A Phenomenon Caused by an Accumulation of Confounders. Am J Gastroenterol, 92, 178–183.Google Scholar
  34. Hampe, J., Cuthbert, A., et al. (2001). Association between insertion mutation in NOD2 gene and CD in German and British populations. Lancet, 357(9272), 1925–1928.PubMedCrossRefGoogle Scholar
  35. Hampe, J., Shaw, S. H., et al. (1999). Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet, 65(6), 1647–1655.PubMedCrossRefGoogle Scholar
  36. Holtzman, N. A., & Watson, M. S. (Eds) (1997). Promoting safe and effective genetic testing in the United States. Final Report of the Task Force on Genetic Testing. http://www.genome.gove/10001733. Accessed August 7, 2006.Google Scholar
  37. Hugot, J. P., Chamaillard, M., et al. (2001). Association of NOD2 leUC ine-rich repeat variants with susceptibility to CD. Nature, 411(6837), 599–603.PubMedCrossRefGoogle Scholar
  38. Jick, H., & Walker, A. M. (1983). Cigarette smoking and ulcerative colitis. N Engl J Med, 308(5), 261–263.PubMedCrossRefGoogle Scholar
  39. Kessler, S., Field, T., et al. (1987). Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet, 26(2), 259–270.PubMedCrossRefGoogle Scholar
  40. Konda, V., Huo, D., Hermes, G., Liu, M., Patel, R., & Rubin, D. T. (2006). Do Patients with Inflammatory Bowel Disease Want Genetic Testing? Inflamm Bowel Dis, 12(6), 497–502.PubMedCrossRefGoogle Scholar
  41. Kornbluth, A., Sachar, D. B., Practice Parameters Committee of the American College of Gastroenterology. (2004). Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol, 99(7), 1371–1385.Google Scholar
  42. Kruiningen, H. J. V., Joossens, M., Vermeire, S., et al. (2005). Environmental Factors in Familial Crohn’s Disease in Belgium. Inflamm Bowel Dis, 11(4), 360–365.PubMedCrossRefGoogle Scholar
  43. Kugathasan, S., Collins, N., Maresso, K., et al. (2004). CARD15 Gene Mutations and Risk for Early Surgery in Pediatric-Onset CD. Clin Gastroenterol Hepatol, 2(11), 1003–1009.PubMedCrossRefGoogle Scholar
  44. Kurata, J. H., Kantor-Fish, S., et al. (1992). CD among ethnic groups in a large health maintenance organization. Gastroenterology, 102(6), 1940–1948.PubMedGoogle Scholar
  45. Langholz, E., Munkholm, P., et al. (1991). Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol, 26(12), 1247–1256.PubMedGoogle Scholar
  46. Louis, E., Peeters, M., Franchimont, D., et al. (2000) Tumour necrosis factor (TNF) gene polymorphism in Crohn’s disease (CD): Influence on disease behaviour? Clin Exp Immunol, 119, 64–68.PubMedCrossRefGoogle Scholar
  47. Loftus, E. (2004). Clinical Epidemiology of Inflammatory Bowel Disease: Incidence, PRevalence, and Environmental Influences. Gastroenterology, 126, 1504–1517.PubMedCrossRefGoogle Scholar
  48. Loftus, E. V., Jr., Silverstein, M. D., et al. (1998). CD in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival. Gastroenterology, 114(6), 1161–1168.PubMedCrossRefGoogle Scholar
  49. Ma, Y., Ohmen, J. D., et al. (1999). A genome-wide search identifies potential new susceptibility loci for CD. Inflamm Bowel Dis, 5(4), 271–278.PubMedCrossRefGoogle Scholar
  50. McConnell, R. B. (1983). Ulcerative colitis - genetic features. Scand J Gastroenterol 88(Supplement), 14–16.Google Scholar
  51. McInerney-Leo, A., Biesecker, B. B., et al. (2004). BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. Am J Med Genet A, 130(3), 221–227.Google Scholar
  52. Monsen, U., Bernell, O., et al. (1991). Prevalence of inflammatory bowel disease among relatives of patients with CD. Scand J Gastroenterol, 26(3), 302–306.Google Scholar
  53. Monsen, U., Iselius, L., et al. (1989). Evidence for a major additive gene in ulcerative colitis. Clin Genet, 36(6), 411–414.PubMedGoogle Scholar
  54. Myers, M. F., Chang, M. H., Jorgensen, C., et al. (2006) Genetic testing for susceptibility to breast and ovarian cancer: Evaluating the impact of a direct-to-consumer marketing campaign on physicians’ knowledge and practices. Genet Med, 8(6), 361–370.PubMedCrossRefGoogle Scholar
  55. Negoro, K., Kinouchi, Y., Iwatashi, H., et al. (1999). Crohn’s disease is associated with novel polymorphism in the 5’-flanking region of th tumor necrosis factor gene. Gastroenterology, 117, 1062–1068.PubMedCrossRefGoogle Scholar
  56. Nemetz, A., Nosti-Escanilla, M. P., Molnar, T., et al (1999). IL1B gene polymorphism influences the course and severity of inflammatory bowel disease. Immunogenetics, 49, 527–531.PubMedCrossRefGoogle Scholar
  57. Neuhausen S. (1999). Ethnic Differences in Cancer Risk Resulting from Genetic Variation. Cancer, 86, 2575–2582.PubMedCrossRefGoogle Scholar
  58. Ogunbi, S. O., Ransom, J. A., et al. (1998). Inflammatory bowel disease in African-American children living in Georgia. J Pediatr, 133(1), 103–107.PubMedCrossRefGoogle Scholar
  59. Ohmen, J. D., Yang, H. Y., et al. (1996). Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in CD, but not in ulcerative colitis. Hum Mol Genet, 5(10), 1679–1683.PubMedCrossRefGoogle Scholar
  60. Oliva-Hemker, M., & Fiocchi, C. (2002). Etiopathogenesis of inflammatory bowel disease: The importance of the pediatric perspective. Inflamm Bowel Dis, 8(2), 112–128.PubMedCrossRefGoogle Scholar
  61. Orholm, M., Binder, V., et al. (2000). Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol, 35(10), 1075–1081.Google Scholar
  62. Orholm, M., Iselius, L., et al. (1993). Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ, 306(6869), 20–24.PubMedCrossRefGoogle Scholar
  63. Pace, F., Molteni, P., Bollani, S., Sarzi-Puttini, P., Stockbrugger, R., Porro, G. B., Drossman, D. A. (2003). Inflammatory bowel disease versus irritable bowel syndrome: A hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol, 38(10), 1031–1038.PubMedCrossRefGoogle Scholar
  64. Pearson, S. R., & Boyce, W. T. (2004). Consultation with the Specialist: The Vulnerable Child Syndrome. Pediatrics Rev, 25, 345–349.Google Scholar
  65. Peltekova, V. D., Wintle, R. F., Rubin, L. A., et al. (2004). Functional variants of OCTN cation transporter genes are associated with Crohn Disease. Nature Genet, 36(5), 471–475.PubMedCrossRefGoogle Scholar
  66. Polito, J. M. (1996). Preliminary evidence for genetic anticipation in Crohn’s disease. Lancet, 347, 798–800.PubMedCrossRefGoogle Scholar
  67. Rioux, J. D., Silverberg, M. S., et al. (2000). Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet, 66(6), 1863–1870.PubMedCrossRefGoogle Scholar
  68. Roth, M. P., Petersen, G. M., et al. (1989). Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology, 96(4), 1016–1020.PubMedGoogle Scholar
  69. Roussomoustakiki, M., Satsangi, J., Welsh, K., et al. (1997) Genetic markers may predict disease behaviour i patiens with ulcerative colitis. Gastroenterology, 112, 1845–1853.CrossRefGoogle Scholar
  70. Rubin, D. T., Konda, V., Lewis, J. R. (2005). Genetic testing for IBD: Focus group analysis of patients and family members. Gastroenterology, 128(4), abstract.Google Scholar
  71. Russel, M. G., Pastoor, C. J., et al. (1997). Familial aggregation of inflammatory bowel disease: A population-based study in South Limburg, The Netherlands. The South Limburg IBD Study Group. Scand J Gastroenterol Suppl, 223, 88–91.Google Scholar
  72. Russell, R. K., Satsangi, J.,(2004), IBD: A family affair. Best Pract Res Clin Gastroenterol, 18(3), 525–539.PubMedCrossRefGoogle Scholar
  73. Sandler, R. S., Sandler, D. P., McDonnell, C. W., et al. (1992). Childhood exposure to environmental tobacco smoke and the risk of ulcerative colitis. Am J Epidemio, 135, 603–608.Google Scholar
  74. Satsangi, J., Grootscholten, C., Holt, H., & Jewell, D. P. (1996). Clinical patterns of Familial Inflammatory Bowel Disease. Gut, 38, 738–741.PubMedGoogle Scholar
  75. Satsangi, J., Jewell, D. P., et al. (1997). The genetics of inflammatory bowel disease. Gut, 40(5), 572–574.PubMedGoogle Scholar
  76. Scheiner, A. P., Sexton, M. E., Rockwood, J., et al. (1985). The vulnerable child syndrome: Fact and theory. J Dev Behav Pediatr, 6(5), 298–301.PubMedCrossRefGoogle Scholar
  77. Sewitch, M. J., Abrahamowicz, M., Bitton, A., et al. (2001) Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol (United States), 96(5), 1470–1479.Google Scholar
  78. Shivananda, S., Lennard-Jones, J., et al. (1996). Incidence of inflammatory bowel disease across Europe: Is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut, 39, 690–697.PubMedGoogle Scholar
  79. Tercyak, K. P., Lerman, C., et al. (2001). Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol, 20(3), 217–222.PubMedCrossRefGoogle Scholar
  80. Thomas, G. A., Millar-Jones, D., et al. (1995). Incidence of CD in Cardiff over 60 years: 1986–1990 an update. Eur J Gastroenterol Hepatol, 7(5), 401–405.PubMedGoogle Scholar
  81. Thomasgard, Trallori, G., Palli, D., et al. (1997). A population-based study of inflammatory bowel disease in Florence over 15 years (1978–92). Scand J Gastroenterol, 31(9), 892–899.Google Scholar
  82. Trachter, A. B., Rogers, A. I., & Leiblum, S. R. (2002) Inflammatory bowel disease in women: Impact on relationship and sexual health. Inflamm Bowel Dis (United States), 8(6), 413–421.Google Scholar
  83. Vare, P. O., Heikius, B., et al. (2001). Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: Is Helicobacter pylori infection a protective factor? Scand J Gastroenterol, 36(12), 1295–1300.PubMedCrossRefGoogle Scholar
  84. Vera, A., Gunson, B. K., et al. (2003). Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation, 75(12), 1983–1988.PubMedCrossRefGoogle Scholar
  85. Watts, D. A., & Satsangi, J. (2002). The genetic jigsaw of inflammatory bowel disease. Gut, 50(Suppl III), iii31–iii36.PubMedCrossRefGoogle Scholar
  86. Wertz, D. C., & Gregg, R. (2000). Genetics services in a social, ethical and policy context: A collaboration between consumers and providers. J Med Ethics, 26(4), 261–265.PubMedCrossRefGoogle Scholar
  87. Weterman, I. T., & Pena, A. S. (1984). Familial incidence of Crohn’s disease in the Netherlands and a review of the literature. Gastroenterology, 35, 93–99.Google Scholar
  88. Yang, H., Taylor, K. D., et al. (2001). Inflammatory bowel disease. I. Genetic epidemiology. Mol Genet Metab, 74(1–2), 1–21.PubMedCrossRefGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2006

Authors and Affiliations

  1. 1.Cancer Risk ClinicThe University of Chicago, Section of Hematology/OncologyChicagoUSA
  2. 2.Section of GastroenterologyThe Reva and David Logan Center for Inflammatory Bowel DiseasesChicagoUSA
  3. 3.MacLean Center for Clinical Medical EthicsThe University of ChicagoChicagoUSA

Personalised recommendations